HOPU Reunion Co Ltd
Affiliated with former director at Ambrx Biopharma, Inc.
- Sold, on record
- None
- Dollars the filings state
- Form 4 sales
- 0
- None on record
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Ambrx Biopharma, Inc.Affiliated with former director
Sales by reason
No Form 4 sale on record for HOPU Reunion Co Ltd.
Timeline
- 1 Form 144 notice Ambrx Biopharma, Inc.NoticeDec 1, 2023 2023
Filed to sell 600,000 shares ($7M)
HOPU Reunion Co Ltd, Affiliated with former director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice Ambrx Biopharma, Inc.NoticeDec 5, 2023 +4 days
Filed to sell 1M shares ($12M)
HOPU Reunion Co Ltd, Affiliated with former director
No 10b5-1 planFirst sale on recordFiling
- 3 Form 144 notice Ambrx Biopharma, Inc.NoticeDec 8, 2023 +3 days
Filed to sell 1.2M shares ($14.9M)
HOPU Reunion Co Ltd, Affiliated with former director
No 10b5-1 planFirst sale on recordFiling
- 4 Form 144 notice Ambrx Biopharma, Inc.NoticeDec 19, 2023 +11 days
Filed to sell 1.4M shares ($20.6M)
HOPU Reunion Co Ltd, Affiliated with former director
No 10b5-1 planFirst sale on recordFiling
- 5 Form 144 notice Ambrx Biopharma, Inc.NoticeDec 26, 2023 +7 days
Filed to sell 1.4M shares ($19.8M)
HOPU Reunion Co Ltd, Affiliated with former director
No 10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | Dec 26, 2023 | Ambrx Biopharma, Inc. | Affiliated with former director | Form 144 notice | 1.4M | $19.8M | Notice | SEC | |
| Dec 19, 2023 | Dec 19, 2023 | Ambrx Biopharma, Inc. | Affiliated with former director | Form 144 notice | 1.4M | $20.6M | Notice | SEC | |
| Dec 8, 2023 | Dec 8, 2023 | Ambrx Biopharma, Inc. | Affiliated with former director | Form 144 notice | 1.2M | $14.9M | Notice | SEC | |
| Dec 5, 2023 | Dec 5, 2023 | Ambrx Biopharma, Inc. | Affiliated with former director | Form 144 notice | 1M | $12M | Notice | SEC | |
| Dec 1, 2023 | Dec 1, 2023 | Ambrx Biopharma, Inc. | Affiliated with former director | Form 144 notice | 600,000 | $7M | Notice | SEC |